Mechanisms Underlying the Efficacy of Prolonged Exposure
Key facts
- Who runs it
- VA Boston Healthcare System
- Where
- Boston, United StatesSee the site
- Trial code
- Status
- Recruiting
- People taking part
- 50 people, planned
- Started
- 1 Jan 2024
- Expected to end
- 1 Jan 2027
- Type of study
- Interventional
- Treatments tested
- Prolonged Exposure Therapy for Posttraumatic Stress Disorder
- Record updated
- 8 April 2025
Who can take part
- Age
- 18 years to 90 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 13 criteriaShow less
Who can take part
- a diagnosis of PTSD as defined by DSM-5 (as indicated by meeting diagnostic criteria on the CAPS-5)
- interest in starting PE (as indicated during the informed consent process)
- Veteran
Who cannot take part
- Current participation in cognitive-behavioral therapy,
- Previously received > 2 sessions of Prolonged Exposure, and
- For participants who are currently prescribed psychotropic medication, they will be eligible for the study provided medication use has been stable for 2 months prior to enrollment and remains stable throughout participation
- Current or past history of schizophrenic or other psychotic disorders,
- Untreated Bipolar Disorder or a history of a manic/mixed episode within the last 6 months,
- Current substance use disorder,
- Severe traumatic brain injury,
- Major neurological problems,
- Active risk to self or others,
- Having no memory of their traumatic event
The main criteria, as questions
These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Are you between 18 and 90 years old?
This trial is currently available in United States.
- VA Boston Healthcare SystemBoston, United StatesContact: Suzanne Pineles, PhDTaking people
About the trial
What the trial wants to find out
The primary objective of this research is to collect pilot data that demonstrates that proposed neural, psychophysiological and subjective markers measured before, during, and after treatment change over the course of Prolonged Exposure therapy (PE) for posttraumatic stress disorder (PTSD). The aims of the study are to: (1) examine theoretically informed mechanisms as pre-treatment predictors of PE treatment efficacy, (2) characterize how neural, psychophysiological, and subjective markers measured before, during, and after treatment change over the course of PE, and (3) examine proposed mechanisms of change as measures of PE treatment efficacy. This is a longitudinal study of predictors of exposure therapy efficacy that will be conducted within the context of a standard 10 session PE treatment trial, with independent multimodal assessment batteries administered at pre-treatment, mid-treatment, post-treatment, and at 1-month follow-up. This data will be used to support a future NIMH and/or VA grant submission.
The group in the trial
- Prolonged Exposure Therapy for Posttraumatic Stress DisorderTreatment being tested
15 participants who meet study inclusion/exclusion criteria will be individually administered a full course of PE during 10, 60 minute-sessions, with independent multimodal assessment batteries administered at pre-treatment, mid-treatment (post session 5), post-treatment, and a 1-month follow-up.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Criteria questions
- Built from NCT05663151, who can take part
- Record updated
- 8 April 2025